omalizumab
Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omalizumab | POWDER FOR INJECTION, SUBCUTANEOUS | 150 mg/mL (1 mL vial) | ||||||||||||||
Omalizumab | SOLUTION, SUBCUTANEOUS | 150 mg/mL (1 mL syringe) | ||||||||||||||
Omalizumab | SOLUTION, SUBCUTANEOUS | 150 mg/mL (0.5 mL) |
UNC Health
System Formulary Restriction:
Use of omalizumab injection is restricted to outpatient encounters or clinic use only (ie, no inpatient use)
UNC Health IV Compendium Guideline
Med Center
UNC Medical Center Formulary Restrictions